SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-07-029136
Filing Date
2007-04-18
Accepted
2007-04-18 15:31:54
Documents
2
Effectiveness Date
2007-04-18

Document Format Files

Seq Description Document Type Size
1 DEFA14A a07-10425_3defa14a.htm DEFA14A 27763
2 GRAPHIC g104253dmi001.gif GRAPHIC 2894
  Complete submission text file 0001104659-07-029136.txt   33384
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-30319 | Film No.: 07773380
SIC: 2834 Pharmaceutical Preparations